[Optimization of the anti-Helicobacter therapy of peptic ulcer on the basis of modern methods of pharmacokinetic analysis].
Bezborodnyĭ
S D
SD
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D005260:Female; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D009853:Omeprazole